COMMUNIQUÉS West-GlobeNewswire

BioAge Labs to Present at Piper Sandler 37th Annual Healthcare Conference
25/11/2025
EMERYVILLE, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases [...]
BiomX Provides Update on BX004 Phase 2b Trial in Cystic Fibrosis
25/11/2025
The Company continues working with the third-party manufacturer to address recent FDA follow-up information requests which are required to lift the clinical hold concerning the nebulizer device used in the Phase 2b [...]
KOMZIFTI™ (ziftomenib) Added to National Comprehensive Cancer Network® (NCCN) Guidelines for Acute Myeloid Leukemia (AML)
25/11/2025
KOMZIFTI, the first and only once-daily FDA-approved menin inhibitor for R/R NPM1-mutated AML, is now commercially available in the United States SAN DIEGO and TOKYO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc [...]
Ascendis Announces Extension of FDA Review Period for TransCon CNP (navepegritide) for Children with Achondroplasia
26/11/2025
– Prescription Drug User Fee Act (PDUFA) goal date extended by three months to February 28, 2026 COPENHAGEN, Denmark, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the U.S. [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 47 - 2025
25/11/2025
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 17 Novembre au 21 Novembre 2025 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 47 - 2025
25/11/2025
Aggregated presentation by day and by market Statement of transactions in own shares from November 17th to November 21st 2025 Name of the issue Identity code of the issuer (Legal Entity Identifier) Day of the [...]
UPDATED: PetVivo AI, Inc. Launches AI Platform Reducing Veterinary Client Acquisition Costs by 50-90%
25/11/2025
Revolutionary PetVivo.ai Uses Nine AI Agents to Transform $150B Pet Care Market Important Disclaimer: This updated press release replaces and supersedes the version issued earlier this morning, which should be [...]
Scilex Holding Company Announces Closing of Exercise of Warrants for $20.3 Million Gross Proceeds
25/11/2025
PALO ALTO, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]
Este Surgery Announces Advanced DHI Hair Transplant Technology in Turkey's Medical Tourism Sector
25/11/2025
Turkey Raises the Bar in Medical Tourism with Advanced DHI Hair Transplant Technology Istanbul, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Turkey's growing share of the global medical tourism market has led to significant [...]
Brown’s Medical Imaging and Prestige Medical Imaging Merge, Expanding Nationwide Service Capabilities
25/11/2025
Combined platform strengthens national footprint, enhances multi-vendor service expertise, and accelerates customer-first innovation OMAHA, Neb., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Brown’s Medical Imaging (“Brown’s” or [...]
Akari Therapeutics Announces Release of the Next CEO Corner Segment
25/11/2025
Access the Akari CEO Corner here BOSTON and LONDON, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payloads for antibody drug conjugates ( [...]
INVO Fertility Announces a 1:8 Reverse Stock Split Effective Pre-Market Opening on November 28, 2025
25/11/2025
SARASOTA, Fla., Nov. 25, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (“INVO”) (NASDAQ: IVF), a healthcare company focused on the fertility market, announced today that it will effect a 1-for-8 reverse split of its [...]
Erasca to Present at the 8th Annual Evercore Healthcare Conference
25/11/2025
SAN DIEGO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/ [...]
Silexion Therapeutics Successfully Completes Toxicology Studies for SIL204, Next-Generation RNA Silencing Therapy, Ahead of Phase 2/3 Clinical Trial in Pancreatic Cancer
25/11/2025
Successful completion of two-species toxicology studies confirms no systemic organ toxicity, advancing the Company towards its planned regulatory submissions to Israel and Germany Company remains on track to initiate [...]
Lancement du Prix AbbVie des innovateurs en biotechnologies au Québec : AbbVie et adMare BioInnovations encouragent l’innovation dans le domaine des sciences de la vie
25/11/2025
Le lancement d’un concours national, en collaboration avec adMare BioInnovations, illustre l’engagement d’AbbVie à favoriser le dynamisme de l’écosystème des biotechnologies au Québec. L’entreprise biotechnologique [...]
AbbVie and adMare BioInnovations Foster Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators Award in Quebec
25/11/2025
National competition, in collaboration with adMare BioInnovations, demonstrates AbbVie's commitment to a thriving biotech ecosystem in Quebec One biotech will receive a year of laboratory and office space including [...]
San Diego’s Premier Neurological-Spine Care Clinic Launches Massive Holiday NUCCA Promotion: 50% Off for New Patients Through Dec. 31
25/11/2025
SAN DIEGO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Just in time for the year-end wellness rush, Origin Modern Health & Wellness is offering 50 % off its signature evaluation and care plan for new patients through December [...]
LifeLabs Donates $10,000 to Women in Crisis in Honour of the International Day for the Elimination of Violence Against Women and Girls.
25/11/2025
Proud to Support a Foundation for a World Free of Gender-Based Violence Toronto, Ontario, Nov. 25, 2025 (GLOBE NEWSWIRE) -- LifeLabs, Canada's leading provider of medical diagnostic services, is proud to donate $10,000 [...]
Branded Legacy Announces Strong Revenues from Newly Acquired Pau Hana Subsidiary
25/11/2025
Pau Hana Plans Ambitious Expansion Roadmap and New Location Acquisitions in the Pipeline MELBOURNE, Fla., Nov. 25, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, Inc. (OTC:BLEG), a leader in innovative addiction [...]

Pages